Examkin

Soru

Zorluk: OrtaNeoplastic Processes

A 6666-year-old man presents to the internal medicine clinic for a routine health maintenance visit. He reports a six-month history of mild urinary urgency, frequency, and nocturia, but denies any weight loss, bone pain, hematuria, or dysuria. He has no significant past medical history. Examination reveals a slightly enlarged, firm, and asymmetric prostate. As part of a comprehensive evaluation for a potential neoplastic process of the prostate, the physician considers the appropriate diagnostic and therapeutic algorithm.

Arrange the following diagnostic and management steps in the most appropriate chronological order according to current oncologic guidelines.

  1. 1Measure serum prostate-specific antigen (PSA) and perform a digital rectal examination (DRE)
  2. 2Obtain a multiparametric MRI (mpMRI) of the prostate to identify and score suspicious lesions
  3. 3Perform a targeted, ultrasound-guided core needle biopsy of the prostate
  4. 4Analyze the histopathologic specimens to determine the Gleason score and overall tumor grade
  5. 5Initiate definitive management, such as active surveillance, radical prostatectomy, or radiation therapy

Cevap

The correct sequence begins with initial screening (PSA and DRE), followed by imaging (multiparametric MRI) to identify biopsy targets, tissue sampling (core needle biopsy), histopathologic evaluation (Gleason scoring), and finally, determining the definitive management plan.
The standard of care for evaluating a potential prostate neoplasm begins with establishing clinical suspicion via PSA and DRE. Because systematic random biopsies have a high false-negative rate, modern oncologic guidelines stipulate obtaining a multiparametric MRI next to identify specific high-risk targets. Once a target is identified, an ultrasound-guided core needle biopsy (often fusing the MRI images) is performed. The resulting tissue is pathologically analyzed to assign a Gleason score. Only after the histologic grade and stage are fully characterized can a definitive management plan, such as active surveillance or surgery, be safely initiated.

Adım Adım Çözüm

1
Measure serum prostate-specific antigen (PSA) and perform a digital rectal examination (DRE).
Establishes initial clinical suspicion and risk level for a prostatic neoplasm.
Non-invasive baseline screening must be performed to justify further advanced imaging or invasive procedures.
2
Obtain a multiparametric MRI (mpMRI) of the prostate.
Locates discrete, suspicious intraprostatic lesions and assigns a PI-RADS score.
Performing an MRI before a biopsy increases the detection of clinically significant cancers and allows for precise targeting.
3
Perform a targeted, ultrasound-guided core needle biopsy.
Procures direct tissue samples from the suspected neoplastic lesions.
Histologic material is required to confirm the presence of malignant cells.
4
Analyze the histopathologic specimens for a Gleason score.
Determines the histologic grade and biologic aggressiveness of the cancer.
Tumor grade is a critical prognostic factor that dictates appropriate treatment pathways.
5
Initiate definitive management.
Provides appropriate oncologic care (e.g., active surveillance or surgery).
Therapy must be tailored to the confirmed diagnosis and risk stratification established in the previous steps.

Anahtar Kavram

Sequential diagnostic and staging algorithm for prostate cancer, prioritizing non-invasive imaging prior to biopsy.
Bu soruyu puanla

Konular

Neoplastic Processes

Bu konudan daha fazla soru